Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism FtsZ inhibitors(bacterial FtsZ inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H10BrF5N2O3 |
InChIKeyONGPJYSSZQHFBU-UHFFFAOYSA-N |
CAS Registry1459695-66-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Staphylococcal Infections | Preclinical | US | 16 Jun 2017 |